State Street Corp Has $91.74 Million Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

State Street Corp trimmed its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 950,560 shares of the health services provider's stock after selling 16,936 shares during the period. State Street Corp owned 2.90% of Amedisys worth $91,739,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in AMED. Calamos Advisors LLC increased its position in shares of Amedisys by 11.6% in the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider's stock worth $36,476,000 after purchasing an additional 41,220 shares during the period. GAM Holding AG bought a new position in Amedisys in the 2nd quarter valued at about $275,000. Innealta Capital LLC acquired a new position in shares of Amedisys in the 2nd quarter valued at approximately $64,000. Signaturefd LLC lifted its holdings in shares of Amedisys by 88.2% during the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock worth $104,000 after acquiring an additional 530 shares during the period. Finally, Commonwealth Equity Services LLC boosted its position in shares of Amedisys by 10.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider's stock worth $381,000 after acquiring an additional 409 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Price Performance

Shares of AMED stock traded down $0.45 during trading hours on Tuesday, reaching $85.37. The company's stock had a trading volume of 484,096 shares, compared to its average volume of 373,871. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a fifty-two week low of $84.06 and a fifty-two week high of $98.95. The company has a market capitalization of $2.80 billion, a price-to-earnings ratio of 34.06, a PEG ratio of 1.84 and a beta of 0.73. The firm's 50 day simple moving average is $92.46 and its 200-day simple moving average is $94.86.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the firm posted $0.98 EPS. The firm's revenue was up 5.7% compared to the same quarter last year. Sell-side analysts forecast that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.